TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 3 | 0 | 1 | 20 | -39 | -2 |
| P | %wins | 67 | 67 | 67 | 67 | 67 | 0 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/06 16:04 | 6/15/06 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Antczak Val R | UT | O | SVP,Lega | P | 21 | 5.16 | 5 | 4 | 19 | 25 | -2 | -6 | -22 | -27 | -3 | -16 | |||||||||
8/26/05 18:50 | 8/24/05 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Antczak Val R | UT | O | Snr. VP, | P | 97 | 9.65 | 4 | 10 | 109 | 19 | D | -63 | -56 | -35 | -21 | -18 | -12 | -3 | 2 | 5 | 8 | 6 | 23 | 53 | -52 |
6/10/05 10:49 | 6/8/05 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Antczak Val R | UT | O | Snr. VP, | P | 93 | 10.89 | 4 | 9 | 999% | 9 | D | -60 | -51 | -39 | -4 | -11 | -16 | -8 | -6 | 1 | 6 | 17 | 7 | 10 | -48 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |